Market Research Logo

Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017

Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Pancreatic Cancer patients study in a new report ‘Global Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Pancreatic Cancer epidemiology, Pancreatic Cancer diagnosed patients, and Pancreatic Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Pancreatic Cancer derived from epidemiological analysis, percentage of patients diagnosed with Pancreatic Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Pancreatic Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Pancreatic Cancer prevalence, Pancreatic Cancer diagnosis rate, and Pancreatic Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Pancreatic Cancer Patient Flow
  • Pancreatic Cancer Prevalence
  • Pancreatic Cancer Diagnosed Patients
  • Pancreatic Cancer Treated Patients


1. Pancreatic Cancer: Disease Definition
2. Global Pancreatic Cancer Patient Flow
2A. Global Pancreatic Cancer Prevalence
2B. Global Pancreatic Cancer Diagnosed Patients
2C. Global Pancreatic Cancer Treated Patients
3. Pancreatic Cancer Patient Flow in the US
3A. Pancreatic Cancer Prevalence in the US
3B. Pancreatic Cancer Diagnosed Patients in the US
3C. Pancreatic Cancer Treated Patients in the US
4. Pancreatic Cancer Patient Flow in Europe
4A. Pancreatic Cancer Prevalence in Europe
4B. Pancreatic Cancer Diagnosed Patients in Europe
4C. Pancreatic Cancer Treated Patients in Europe
5. Pancreatic Cancer Patient Flow in Germany
5A. Pancreatic Cancer Prevalence in Germany
5B. Pancreatic Cancer Diagnosed Patients in Germany
5C. Pancreatic Cancer Treated Patients in Germany
6. Pancreatic Cancer Patient Flow in France
6A. Pancreatic Cancer Prevalence in France
6B. Pancreatic Cancer Diagnosed Patients in France
6C. Pancreatic Cancer Treated Patients in France
7. Pancreatic Cancer Patient Flow in Spain
7A. Pancreatic Cancer Prevalence in Spain
7B. Pancreatic Cancer Diagnosed Patients in Spain
7C. Pancreatic Cancer Treated Patients in Spain
8. Pancreatic Cancer Patient Flow in Italy
8A. Pancreatic Cancer Prevalence in Italy
8B. Pancreatic Cancer Diagnosed Patients in Italy
8C. Pancreatic Cancer Treated Patients in Italy
9. Pancreatic Cancer Patient Flow in UK
9A. Pancreatic Cancer Prevalence in UK
9B. Pancreatic Cancer Diagnosed Patients in UK
9C. Pancreatic Cancer Treated Patients in UK
10. Pancreatic Cancer Patient Flow in Japan
10A. Pancreatic Cancer Prevalence in Japan
10B. Pancreatic Cancer Diagnosed Patients in Japan
10C. Pancreatic Cancer Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Pancreatic Cancer Patient Flow, 2016
Table 2: Global Pancreatic Cancer Patient Flow Forecast, 2016 - 2025
Table 3: Pancreatic Cancer Patient Flow in the US, 2016
Table 4: Pancreatic Cancer Patient Flow Forecast in the US, 2016 - 2025
Table 5: Pancreatic Cancer Patient Flow in Europe, 2016
Table 6: Pancreatic Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Pancreatic Cancer Patient Flow in Germany, 2016
Table 8: Pancreatic Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Pancreatic Cancer Patient Flow in France, 2016
Table 10: Pancreatic Cancer Patient Flow Forecast in France, 2016 - 2025
Table 11: Pancreatic Cancer Patient Flow in Spain, 2016
Table 12: Pancreatic Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Pancreatic Cancer Patient Flow in Italy, 2016
Table 14: Pancreatic Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Pancreatic Cancer Patient Flow in UK, 2016
Table 16: Pancreatic Cancer Patient Flow Forecast in UK, 2016 - 2025
Table 17: Pancreatic Cancer Patient Flow in Japan, 2016
Table 18: Pancreatic Cancer Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Pancreatic Cancer Patient Flow, 2016
Figure 2: Global Pancreatic Cancer Patient Flow Forecast, 2016 - 2025
Figure 3: Pancreatic Cancer Patient Flow in the US, 2016
Figure 4: Pancreatic Cancer Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Pancreatic Cancer Patient Flow in Europe, 2016
Figure 6: Pancreatic Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Pancreatic Cancer Patient Flow in Germany, 2016
Figure 8: Pancreatic Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Pancreatic Cancer Patient Flow in France, 2016
Figure 10: Pancreatic Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 11: Pancreatic Cancer Patient Flow in Spain, 2016
Figure 12: Pancreatic Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Pancreatic Cancer Patient Flow in Italy, 2016
Figure 14: Pancreatic Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Pancreatic Cancer Patient Flow in UK, 2016
Figure 16: Pancreatic Cancer Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Pancreatic Cancer Patient Flow in Japan, 2016
Figure 18: Pancreatic Cancer Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report